McCleary NJ, Meyerhardt JA, Green E, Yothers G, de Gramont A, Van Cutsem E, O’Connell MJ, Twelves CJ, Saltz LB, Sargent DJ, Haller D. Impact of age on the efficacy of newer adjuvant therapies in 14,528 patients with stage II/III colon cancer: Findings from the ACCENT Database. J Clin Oncol. 2013 – in press
McCleary NJ, Odejide O, Szymonifka J, Ryan D, Hezel A, Meyerhardt JA. Safety and effectiveness of oxaliplatin-based chemotherapy regimens in adults 75 years and older with colorectal cancer. Clin Colorectal Cancer 2012 - in press
McCleary NJ, Wigler, D, Berry D, Sato K, Abrams T, Chan J, Enzinger P, Ng K, Wolpin B, Schrag D, Fuchs CS, Hurria A, Meyerhardt JA. Feasibility of computer-based self-administered cancer-specific geriatric assessment in older pts with gastrointestinal malignancy. Oncologist 2012 – in press
Jackson McCleary N, Niedzwiecki D, Hollis D, Saltz L, Mayer R, Schaefer P, Whittom R, Hantel A, Benson A, Goldberg R, Meyerhardt J. The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803. Cancer. 2010 February 15; 116 (4): 957-966. PMID: 20052723. PMCID: PMC2884300.
Jackson McCleary N, Meyerhardt J. New developments in the adjuvant therapy of stage II colon cancer: Risk assessments in the older patient. Oncology. 2010 January; 24 (1). PMID: 20225605.
Jackson N, Barrueco J, Soufi-Mahjoubi R, Marshall J, Mitchell E, Zhang X, Meyerhardt J. Comparing Safety and Efficacy of First-Line Irinotecan/Fluoropyrimidine Combinations in Elderly versus Nonelderly Patients with Metastatic Colorectal Cancer: Findings from the BICC-C Study. Cancer. 2009 June 15; 115 (12): 2617-29. PMID: 19382200.